Cardiac remodeling in severe hypertension, does it respond to tight blood pressure control?

Faculty Medicine Year: 2022
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Cardiovascular Research Oxford Academic Volume:
Keywords : Cardiac remodeling , severe hypertension, does , respond    
Abstract:
Severe hypertension (HTN) may cause target organ damage (TOD). Kidney can tolerate severe HTN to very high levels. Cardiac remodeling as TOD could be detected by elevation of biomarker Troponin. Aim We aim to detect the response of organs (heart & kidney) to tight control of severe HTN. Patients & Methods Patients admitted due to severe hypertension (BP> 180/120) associated with any symptoms were enrolled. All patients were managed according to the European guidelines to the target BP. Cardiac biomarker Hs-Troponin T (hs-TNT) and serum creatinine (s.creat) were measured for all patients on admission and 24hours later. Results Ninty five patients with hypertensive crisis were treated to target BP. Forty six patients had initially high hs-TNT (Group A) and 49 patients had initially normal hs-TNT (Group B). There was a highly significant difference between both groups regarding initial and follow-up s.creat with higher values in Group B (P= 0.03 and 0.004 respectively).There was high significant difference between initial and follow up s.creat values in Group B with higher values in the follow up measurements after BP control to the target (P= 0.03), while this difference is insignificant in Group A (P=0.26). Five patients in Group B developed renal failure after tight BP control. There was a significant positive correlation between hs-TNT and the follow-up s.creat (P=0.018) with more deterioration of s.creat in those having initial high hs-TNT. Conclusion In severe HTN, hs-TNT may be elevated due to marked afterload. Renalaffection and TOD occurs before cardiac remodeling and damage due to severe HTN. Renal autoregulation occurs in chronic elevation of BP. Acute control of severe HTN leads to disrruption of renal autoregulation and renal shut down. European guidelines regarding severe HTN control should be revised. In hypertensive patients with high hs-TNT, BP should not be well controlled on the short term not to disrupt renal autoregulation.
   
     
 
       

Author Related Publications

  • Mohammed Abdullah Al- Mahmoud Altahlaoy, "Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study", OXFORD, 2021 More
  • Mohammed Abdullah Al- Mahmoud Altahlaoy, "Role of MDCT renal angiography in determining the anatomical eligibility for renal sympathetic denervation in resistant hypertensive patients", Elsevier, 2018 More
  • Mohammed Abdullah Al- Mahmoud Altahlaoy, "Computed Tomography Imaging Assessment of the Effect of Vancomycin Paste on Poststernotomy Healing", Dovepress, 2021 More
  • Mohammed Abdullah Al- Mahmoud Altahlaoy, "Post infarction arrest with normal coronaries and delayed heart failure", Oxford, 2016 More
  • Mohammed Abdullah Al- Mahmoud Altahlaoy, "Does pulmonary hypertension impact clinical outcome or mortality in dilated cardiomyopathy patients?", Oxford, 2016 More

Department Related Publications

  • Ahmed Shafea Mahmoud Morsy, "قيمه سمك الطانه والطبقة الوسطي للشريان السباتي والفخذي كعامل غير نافذ للتنبؤ بمرض الشريان التاجي", مجلة القلب المصرية, 2001 More
  • Ahmed Shafea Mahmoud Morsy, "تاثير توسيع الصمام الميترالي بالقسطره البالونية علي الارتجاع الوظيفي للصمام ثلاثي الشرفات وارتفاع ضغط الشريان الرئوي", مجلة جامعة الزقازيق الطبية, 2000 More
  • Tarek Abdelmoniem Abdelaziz, "Human C-reactive protein gene polymorphism andmetabolic syndrome are associated with premature coronary artery disease", Elsevier, 2013 More
  • Tarek Abdelmoniem Abdelaziz, "Synergistic Effect Between Lipoprotein Lipase and Apolipoprotein C3 Genes in Determining the Severity of Coronary Artery Disease", Springer, 2013 More
  • Eslam Alsayed Mohamed Mohamed Shehata, "Mitral annulus time intervals for assessment of left ventricular systolic function in ischemic cardiomyopathy", European Journal of Heart Failure Supplements (2012) 11, S128–S177, 2012 More
Tweet